fingolimod
fingolimod is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including fingolimod, FINGOLIMOD. Available dosage form: capsule.
Drug Details
- Generic Name
- fingolimod
- Brand Names
- fingolimod, FINGOLIMOD
- Application Number
- ANDA207985
- Sponsor
- Glenmark Pharmaceuticals Inc., USA
- NDC Codes
- 2
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- FINGOLIMOD HYDROCHLORIDE, FINGOLIMOD
Indications and Usage
1 INDICATIONS AND USAGE Fingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. Fingolimod capsules are a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. ( 1 )